TrialJCI insight2018

Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma.

Alfred L Garfall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.